Abstract
Concentration of dopamine and serotonin metabolites (HVA and 5-HIAA) in the CSF was evaluated before and after pharmacological treatment in 19 patients with different neuropsychiatric diseases. In every case a reciprocal modification of the two metabolites occurred after treatment. The result supports the hypothesis of a functional balance between the monoaminergic systems in the central nervous system.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carlsson A., Biswas B., Lindqvist M. Influence of GABA and GABA-like drugs on monoaminergic mechanisms. Adv Biochem Psychopharmacol. 1977;16:471–475. [PubMed] [Google Scholar]
- Corrodi H., Farnebo L. O., Fuxe K., Hamberger B., Ungerstedt U. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol. 1972 Nov;20(2):195–204. doi: 10.1016/0014-2999(72)90149-5. [DOI] [PubMed] [Google Scholar]
- Goodwin F. K., Post R. M. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis. Res Publ Assoc Res Nerv Ment Dis. 1975;54:299–332. [PubMed] [Google Scholar]
- Green A. R., Youdim M. B., Grahame-Smith D. G. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Neuropharmacology. 1976 Mar;15(3):173–179. doi: 10.1016/0028-3908(76)90026-5. [DOI] [PubMed] [Google Scholar]
- Heal D. J., Green A. R., Boullin D. J., Grahame-Smith D. G. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa. Psychopharmacology (Berl) 1976 Sep 29;49(3):287–300. doi: 10.1007/BF00426832. [DOI] [PubMed] [Google Scholar]
- Hornykiewicz O. Neurohumoral interactions and basal ganglia function and dysfunction. Res Publ Assoc Res Nerv Ment Dis. 1976;55:269–280. [PubMed] [Google Scholar]
- Korf J., Ottema S., van der Veen I. Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. Anal Biochem. 1971 Mar;40(1):187–191. doi: 10.1016/0003-2697(71)90091-1. [DOI] [PubMed] [Google Scholar]
- Korf J., van Praag H. M., Sebens J. B. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol. 1971 Mar;20(3):659–668. doi: 10.1016/0006-2952(71)90152-3. [DOI] [PubMed] [Google Scholar]
- Roccatagliata G., Albano C., Besio G., Ivaldi E. M. Discinesie coreiche e Gaba - approccio farmaco-clinico. Nota preliminare. Schweiz Arch Neurol Neurochir Psychiatr. 1978;123(1):63–68. [PubMed] [Google Scholar]
- Roos B. E. Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J Pharm Pharmacol. 1969 Apr;21(4):263–264. doi: 10.1111/j.2042-7158.1969.tb08243.x. [DOI] [PubMed] [Google Scholar]
- STENGEL E. Classification of mental disorders. Bull World Health Organ. 1959;21:601–663. [PMC free article] [PubMed] [Google Scholar]
